Morgan Stanley Avidity Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 611,237 shares of RNA stock, worth $26.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

611,237

Previous 1,254,234 51.27%

Holding current value

$26.7 Million

Previous $51.2 Million 45.21%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$37.21 - $48.14 $23.9 Million - $31 Million	-642,997 Reduced 51.27%	611,237 $28.1 Million
Q2 2024 Oct 17, 2024	SELL	$22.73 - $40.85 $6.43 Million - $11.6 Million	-283,062 Reduced 18.41%	1,254,234 $51.2 Million
Q2 2024 Aug 14, 2024	SELL	$22.73 - $40.85 $6.43 Million - $11.6 Million	-283,062 Reduced 18.41%	1,254,234 $51.2 Million
Q1 2024 Oct 17, 2024	BUY	$9.16 - $25.52 $2.59 Million - $7.22 Million	283,062 Added 22.57%	1,537,296 $39.2 Million
Q1 2024 Aug 16, 2024	BUY	$9.16 - $25.52 $426,425 - $1.19 Million	46,553 Added 3.12%	1,537,296 $39.2 Million
Q1 2024 May 15, 2024	BUY	$9.16 - $25.52 $426,425 - $1.19 Million	46,553 Added 3.12%	1,537,296 $39.2 Million
Q4 2023 Aug 16, 2024	BUY	$4.87 - $9.37 $1.15 Million - $2.22 Million	236,509 Added 18.86%	1,490,743 $13.5 Million
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $1.62 Million - $3.12 Million	333,161 Added 28.78%	1,490,743 $13.5 Million
Q3 2023 Nov 15, 2023	BUY	$6.3 - $11.35 $371,618 - $669,502	58,987 Added 5.37%	1,157,582 $7.39 Million
Q2 2023 Aug 14, 2023	SELL	$10.62 - $17.34 $1.63 Million - $2.67 Million	-153,867 Reduced 12.29%	1,098,595 $12.2 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $3.49 Million - $5.84 Million	227,610 Added 22.21%	1,252,462 $19.2 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $9.5 Million - $21.4 Million	944,272 Added 1171.84%	1,024,852 $22.7 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $829,413 - $1.26 Million	-53,649 Reduced 39.97%	80,580 $1.32 Million
Q2 2022 Oct 27, 2022	BUY	$11.18 - $20.5 $277,901 - $509,568	24,857 Added 22.73%	134,229 $1.95 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $277,901 - $509,568	24,857 Added 22.73%	134,229 $1.95 Million
Q1 2022 Oct 27, 2022	SELL	$14.2 - $23.78 $352,969 - $591,099	-24,857 Reduced 18.52%	109,372 $2.02 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $490,681 - $821,717	34,555 Added 46.19%	109,372 $2.02 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $979,607 - $1.38 Million	-48,020 Reduced 39.09%	74,817 $1.78 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $2.23 Million - $3.1 Million	122,837 New	122,837 $3.03 Million

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account